Asset Acquisitions and Disposals::PROPOSED DISPOSAL OF THE REMAINING 12% EQUITY INTEREST IN TIANJIN TSKF PHARMACEUTICAL CO., LTD.

Issuer & Securities

Issuer/ Manager
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED
Securities
TIANJIN PHARM DA REN TANG GRP - CNE100000924 - T14
Stapled Security
No

Announcement Details

Announcement Title
Asset Acquisitions and Disposals
Date &Time of Broadcast
15-Apr-2025 17:31:01
Status
New
Announcement Sub Title
PROPOSED DISPOSAL OF THE REMAINING 12% EQUITY INTEREST IN TIANJIN TSKF PHARMACEUTICAL CO., LTD.
Announcement Reference
SG250415OTHR13G5
Submitted By (Co./ Ind. Name)
Jiao Yan
Designation
Secretary to the Board
Description (Please provide a detailed description of the event in the box below)
PROPOSED DISPOSAL OF THE REMAINING 12% EQUITY INTEREST IN TIANJIN TSKF PHARMACEUTICAL CO., LTD. TO HALEON CHINA CO., LTD. AND HALEON CH SARL, AND ENTRY INTO AN EQUITY TRANSFER AGREEMENT IN RELATION THERETO

Attachments

20250415 TJ DRT - Proposed Disposal of Remaining 12 Equity Interest in TSKF.pdf
Total size =577K